Shopping Cart
Remove All
Your shopping cart is currently empty
Suciraslimab (Synonyms: SM03, SM 03)
Catalog No. T9901A-522 Copy Product Info
🥰Excellent
Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases.
Suciraslimab
Copy Product Info🥰Excellent
Catalog No. T9901A-522
Synonyms SM03, SM 03
Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases.
Suciraslimab
Cas No. 2415439-63-1
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $953 | - | In Stock | |
| 25 mg | $1,390 | - | In Stock | |
| 50 mg | $1,880 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:>95.0% (SDS-PAGE); 97.42% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases. |
| In vivo | In 5xFAD Alzheimer's disease mouse models, intraperitoneal injection of Suciraslimab (10 mg/kg, once weekly for 4 weeks) significantly enhanced microglial metabolic activity and phagocytosis, reduced brain amyloid plaque burden, and upregulated neuroprotective gene expression[1]. |
| Synonyms | SM03, SM 03 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD22 Protein (His) at 2 μg/mL can bind Suciraslimab. The EC50 is 0.004412 μg/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Siglec-2/CD22 |
| Molecular Weight | 146.16 kDa |
| Cas No. | 2415439-63-1 |
| Isotype | Human IgG1-REM kappa |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Suciraslimab | purchase Suciraslimab | Suciraslimab cost | order Suciraslimab | Suciraslimab in vivo | Suciraslimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.